AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on ... - Genetic Engineering News (press release) PDF Print
Genetic Engineering News (press release)Dr. Hutson's presentation, entitled "Phase 2 study of perifosine in patients with metastatic renal cell carcinoma progressing after prior therapy with both ...Updated Single Agent Phase 2 Data of KRX-0401 (Perifosine) in the ... Earthtimes (press release)Keryx Biopharma Announces Updated Clinical Results From Phase 2 ... RTT NewsKeryx Biopharmaceuticals, Inc. to Raise $20 Million in Registered

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129